Works matching IS 0008543X AND DT 2023 AND VI 129

Results: 519
    1
    2
    3
    4
    5
    6
    7
    8
    9
    10
    11

    A phase 2 study of ibrutinib maintenance following first‐line high‐dose methotrexate‐based chemotherapy for elderly patients with primary central nervous system lymphoma.

    Published in:
    Cancer (0008543X), 2023, v. 129, n. 24, p. 3905, doi. 10.1002/cncr.34985
    By:
    • Bairey, Osnat;
    • Taliansky, Alisa;
    • Glik, Amir;
    • Amiel, Alexandra;
    • Yust‐Katz, Shlomit;
    • Gurion, Ronit;
    • Zektser, Miri;
    • Porges, Tzvika;
    • Sarid, Nadav;
    • Horowitz, Netanel A.;
    • Shina, Tzahala Tzuk;
    • Lebel, Eyal;
    • Cohen, Amos;
    • Geiger, Karyn Revital;
    • Raanani, Pia;
    • Wolach, Ofir;
    • Siegal, Tali
    Publication type:
    Article
    12
    13

    Comprehensive genomic profiling of penile squamous cell carcinoma and the impact of human papillomavirus status on immune‐checkpoint inhibitor‐related biomarkers.

    Published in:
    Cancer (0008543X), 2023, v. 129, n. 24, p. 3884, doi. 10.1002/cncr.34982
    By:
    • Nazha, Bassel;
    • Zhuang, Tony;
    • Wu, Sharon;
    • Brown, Jacqueline T.;
    • Magee, Daniel;
    • Carthon, Bradley C.;
    • Kucuk, Omer;
    • Nabhan, Chadi;
    • Barata, Pedro C.;
    • Heath, Elisabeth I.;
    • Ryan, Charles J.;
    • McKay, Rana R.;
    • Master, Viraj A.;
    • Bilen, Mehmet Asim
    Publication type:
    Article
    14
    15
    16
    17
    18
    19
    20
    21

    Issue Information.

    Published in:
    Cancer (0008543X), 2023, v. 129, n. 24, p. 3833, doi. 10.1002/cncr.33739
    Publication type:
    Article
    22
    23
    24
    25
    26

    What are the most effective exercise, physical activity and dietary interventions to improve body composition in women diagnosed with or at high‐risk of breast cancer? A systematic review and network meta‐analysis.

    Published in:
    Cancer (0008543X), 2023, v. 129, n. 23, p. 3697, doi. 10.1002/cncr.35043
    By:
    • Kudiarasu, Christine;
    • Lopez, Pedro;
    • Galvão, Daniel A.;
    • Newton, Robert U.;
    • Taaffe, Dennis R.;
    • Mansell, Lorna;
    • Fleay, Brianna;
    • Saunders, Christobel;
    • Fox‐Harding, Caitlin;
    • Singh, Favil
    Publication type:
    Article
    27
    28

    Larotrectinib efficacy and safety in adult patients with tropomyosin receptor kinase fusion sarcomas.

    Published in:
    Cancer (0008543X), 2023, v. 129, n. 23, p. 3772, doi. 10.1002/cncr.35036
    By:
    • Kummar, Shivaani;
    • Shen, Lin;
    • Hong, David S.;
    • McDermott, Ray;
    • Keedy, Vicki L.;
    • Casanova, Michela;
    • Demetri, George D.;
    • Dowlati, Afshin;
    • Melcón, Soledad Gallego;
    • Lassen, Ulrik N.;
    • Leyvraz, Serge;
    • Liu, Tianshu;
    • Moreno, Victor;
    • Patel, Jyoti;
    • Patil, Tejas;
    • Mallick, Atrayee Basu;
    • Sousa, Nuno;
    • Tahara, Makoto;
    • Ziegler, David S.;
    • Norenberg, Ricarda
    Publication type:
    Article
    29
    30
    31
    32
    33

    Oncology hospitalist impact on hospice utilization.

    Published in:
    Cancer (0008543X), 2023, v. 129, n. 23, p. 3797, doi. 10.1002/cncr.35008
    By:
    • Prsic, Elizabeth;
    • Morris, Jensa C.;
    • Adelson, Kerin B.;
    • Parker, Nathaniel A.;
    • Gombos, Erin A.;
    • Kottarathara, Mathew J.;
    • Novosel, Madison;
    • Castillo, Lawrence;
    • Gould Rothberg, Bonnie E.
    Publication type:
    Article
    34
    35
    36

    Posttransplant cyclophosphamide versus antithymocyte globulin in patients with acute lymphoblastic leukemia treated with allogeneic hematopoietic cell transplantation from matched unrelated donors: A study from the Acute Leukemia Working Party of the European Society for Blood and Marrow Transplantation

    Published in:
    Cancer (0008543X), 2023, v. 129, n. 23, p. 3735, doi. 10.1002/cncr.35004
    By:
    • Giebel, Sebastian;
    • Labopin, Myriam;
    • Salmenniemi, Urpu;
    • Socié, Gerard;
    • Bondarenko, Sergey;
    • Blaise, Didier;
    • Kröger, Nicolaus;
    • Vydra, Jan;
    • Grassi, Anna;
    • Bonifazi, Francesca;
    • Czerw, Tomasz;
    • Anagnostopoulos, Achilles;
    • Lioure, Bruno;
    • Ruggeri, Annalisa;
    • Savani, Bipin;
    • Spyridonidis, Alexandros;
    • Sanz, Jaime;
    • Peric, Zinaida;
    • Nagler, Arnon;
    • Ciceri, Fabio
    Publication type:
    Article
    37

    Single‐agent belantamab mafodotin in patients with relapsed/refractory multiple myeloma: Final analysis of the DREAMM‐2 trial.

    Published in:
    Cancer (0008543X), 2023, v. 129, n. 23, p. 3746, doi. 10.1002/cncr.34987
    By:
    • Nooka, Ajay K.;
    • Cohen, Adam D.;
    • Lee, Hans C.;
    • Badros, Ashraf;
    • Suvannasankha, Attaya;
    • Callander, Natalie;
    • Abdallah, Al‐Ola;
    • Trudel, Suzanne;
    • Chari, Ajai;
    • Libby, Edward N.;
    • Chaudhry, Maria;
    • Hultcrantz, Malin;
    • Kortüm, K. Martin;
    • Popat, Rakesh;
    • Sborov, Douglas;
    • Hakim, Shawn;
    • Lewis, Eric;
    • Gorsh, Boris;
    • Bhushan, Bharat;
    • McKeown, Astrid
    Publication type:
    Article
    38
    39
    40
    41
    42
    43
    44

    Issue Information.

    Published in:
    Cancer (0008543X), 2023, v. 129, n. 23, p. 3671, doi. 10.1002/cncr.33737
    Publication type:
    Article
    45
    46
    47
    48
    49
    50